Early diagnosis of cardiotoxic complications of chemotherapy: the possibility of radiation research methods
Author(s) -
M. V. Chistyakovа,
E. V. Goncharova
Publication year - 2018
Publication title -
kardiologiia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.159
H-Index - 16
eISSN - 2412-5660
pISSN - 0022-9040
DOI - 10.18087/cardio.2512
Subject(s) - medicine , cardiotoxicity , cancer , myocardial ischemia , chemotherapy , intensive care medicine , heart failure , cardiology , radiation therapy , cause of death , chemotherapeutic drugs , ischemia , disease
Oncological diseases are the main causes of death in the world. Modern treatment of cancer patients contributes to an increase in survival rate due to strong chemotherapeutic drugs, the use of which is accompanied by toxic effects on cardiomyocytes. The main manifestations of cardiotoxicity are left ventricular dysfunction, myocardial ischemia, thromboembolic complications, chronic heart failure. As a result, the risk of cardiovascular mortality may be higher than the risk of death from the tumor process. An important task of oncologists and cardiologists is the early diagnosis of cardiotoxic complications in order to start treatment in time and reduce mortality from cardiovascular pathology in cancer patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom